3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Phase 2/3
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
226
Breast Neoplasms
223
Prostatic Neoplasms
163
Multiple Myeloma
147
Neoplasms
130
Leukemia, Myeloid, Acute
117
Colorectal Neoplasms
117
Lung Neoplasms
112
Neoplasm Metastasis
95
Squamous Cell Carcinoma of Head and Neck
90
Carcinoma, Hepatocellular
88
Melanoma
83
Lymphoma
81
Triple Negative Breast Neoplasms
74
Pancreatic Neoplasms
73
Ovarian Neoplasms
72
Sarcoma
66
Lymphoma, Large B-Cell, Diffuse
63
Carcinoma, Renal Cell
63
Brain Neoplasms
62
Recurrence
58
Head and Neck Neoplasms
57
Stomach Neoplasms
54
Precursor Cell Lymphoblastic Leukemia-Lymphoma
54
Leukemia, Lymphocytic, Chronic, B-Cell
53
Urinary Bladder Neoplasms
52
Hematologic Neoplasms
52
Lymphoma, Non-Hodgkin
51
Small Cell Lung Carcinoma
50
Endometrial Neoplasms
47
Interventions
mirdametinib
1
Alpelisib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Lymphatic Abnormalities
×
90 days
×
Clear all
NCT05983159
2026-05-05
TARGET-VM
Murdoch Childrens Research Institute
Phase 2
Recruiting
50 enrolled